We are live on ! Find out more
LBPSW

4D Pharma PLC Warrant
LBPSW

Delisted

LBPSW was delisted on the 29th of June, 2022.

6 hedge funds and large institutions have $202K invested in 4D Pharma PLC Warrant in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more funds holding

Funds holding: 56 (+1)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

93% less capital invested

Capital invested by funds: $2.81M → $202K (-$2.61M)

Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BFM
1
Boothbay Fund Management
New York
$133K
AA
2
AQR Arbitrage
Connecticut
$25K +$11.3K +27,173 +76%
HF
3
HRT Financial
New York
$20K -$3.75K -9,036 -13%
YCM
4
Yakira Capital Management
Connecticut
$17K -$2.07K -5,000 -11%
Walleye Capital
5
Walleye Capital
New York
$6K +$6.63K +16,000 New
UBS Group
6
UBS Group
Switzerland
$1K +$750 +1,810 +137%

LBPSW Hedge Fund Activity: Q1 2022 in Review

6 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in 4D Pharma PLC Warrant (LBPSW) for Q1 2022, worth a combined $202K — down 93% from $2.81M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new LBPSW positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.

The largest buyer was AQR Arbitrage, adding an estimated $11.3K. The largest seller was HRT Financial, cutting an estimated $3.75K.

  • 6 institutional investors held 4D Pharma PLC Warrant (LBPSW) as of Q1 2022, up from 5 in Q4 2021.
  • Funds reported $202K of 4D Pharma PLC Warrant stock for Q1 2022, down 93% quarter-over-quarter.
  • 1 fund opened new 4D Pharma PLC Warrant positions in Q1 2022 and 0 closed out, a net change of +1 holder.
  • The largest 4D Pharma PLC Warrant buyer in Q1 2022 was AQR Arbitrage, an estimated $11.3K added.
  • The largest 4D Pharma PLC Warrant seller in Q1 2022 was HRT Financial, an estimated $3.75K sold.

Based on aggregated 13F filings for Q1 2022.